What is Mclab?
Molecular Cloning Laboratories (MCLAB) is a BioTech company headquartered in South San Francisco, specializing in a comprehensive suite of molecular biology and biotechnology services and products. Their core offerings encompass various DNA services, including sequencing, PCR cloning, and Next-Generation Sequencing (NGS) services. Additionally, MCLAB provides a range of products such as enzymes, nucleic acid purification kits, and protein purification solutions. The company primarily serves researchers and professionals within the life sciences, equipping them with essential tools and reagents for genetic analysis and manipulation. MCLAB's commitment to high-quality laboratory services supports advancements in genomics and proteomics.
How much funding has Mclab raised?
Mclab has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Mclab?
The substantial capital infusion, characterized as a large-scale late-stage funding, indicates Mclab's strategic intent to scale operations, potentially through market expansion, product development acceleration, or strategic acquisitions. This financing round, described as a major strategic investment, suggests a focus on solidifying its market position and enhancing its competitive edge in the biotechnology services and products landscape. Future endeavors will likely involve leveraging these resources to further innovate in areas like DNA services and purification solutions, catering to the evolving needs of the life sciences research community.
See full Mclab company page
